Know Cancer

or
forgot password

Oxygenation of the Prostate Gland: a Polarographic Electrode Study in Men Undergoing Prostate Biopsy.


Phase 2
18 Years
N/A
Not Enrolling
Male
Prostatic Neoplasms

Thank you

Trial Information

Oxygenation of the Prostate Gland: a Polarographic Electrode Study in Men Undergoing Prostate Biopsy.


Inclusion Criteria:



- Men due to undergo sextant prostate biopsy

- Serum PSA <10 ng/ml

Exclusion Criteria:

- Previous diagnosis of prostate cancer

- Inability to give informed consent

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Median pO2 and HP5 will be analyzed according to the presence or absence of tumour on biopsy

Outcome Time Frame:

7 years

Safety Issue:

No

Principal Investigator

Michael Milosevic, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Princess Margaret Hospital, Canada

Authority:

Canada: Health Canada

Study ID:

UHN REB 01-0102-C

NCT ID:

NCT00152789

Start Date:

April 2001

Completion Date:

March 2008

Related Keywords:

  • Prostatic Neoplasms
  • Neoplasms
  • Prostatic Neoplasms

Name

Location